Tempus AI, Inc. (NASDAQ:TEM) CFO Sells $59,057.64 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 1,468 shares of the company’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $40.23, for a total value of $59,057.64. Following the transaction, the chief financial officer now directly owns 229,812 shares in the company, valued at $9,245,336.76. This represents a 0.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

James William Rogers also recently made the following trade(s):

• On Wednesday, December 11th, James William Rogers sold 83,025 shares of Tempus AI stock. The shares were sold at an average price of $42.30, for a total value of $3,511,957.50.

Tempus AI Trading Down 12.0 %

Shares of Tempus AI stock traded down $4.66 during trading on Wednesday, hitting $34.29. The stock had a trading volume of 7,396,915 shares, compared to its average volume of 1,521,735. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49. The company’s 50-day moving average price is $52.24.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors have recently added to or reduced their stakes in TEM. Kovitz Investment Group Partners LLC bought a new position in shares of Tempus AI in the 3rd quarter worth $1,367,000. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after acquiring an additional 1,145,698 shares during the last quarter. Captrust Financial Advisors bought a new position in Tempus AI in the third quarter valued at $2,726,000. Sigma Planning Corp purchased a new stake in Tempus AI during the third quarter valued at about $1,323,000. Finally, Dakota Wealth Management bought a new stake in Tempus AI during the third quarter worth about $1,185,000. 24.22% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Piper Sandler reiterated a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and raised their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Loop Capital lifted their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Bank of America increased their target price on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Finally, Guggenheim assumed coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $56.00.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.